Following the negative Phase I trial outcome for its autoimmune disease treatment, the company is cutting 73% of jobs.

Team Gleason has expanded its collaboration with Stentrode developer Synchron to help teach people about brain-computer ...

For men, high levels of physical activity and fitness are associated with reduced risk of amyotrophic lateral sclerosis (ALS).

Eli Lilly and Alchemab Therapeutics have partnered to develop new therapies for amyotrophic lateral sclerosis (ALS). The ...

Misses from amyotrophic lateral sclerosis hopefuls Denali Therapeutics and partners AbbVie and Calico Life Sciences mark the ...